申请人:Array BioPharma Inc.
公开号:US20140100369A1
公开(公告)日:2014-04-10
Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
式I的化合物对于CHK1和/或CHK2的抑制是有用的。本文揭示了使用式I的化合物及其立体异构体和药学上可接受的盐,在哺乳动物细胞的体外、体内和原位诊断、预防或治疗这种疾病或相关病理条件的方法。